Cargando…
The effect of fecal microbiota transplantation on Hepatic myelopathy: A case report
RATIONALE: Hepatic myelopathy (HM), also known as portal-systemic myelopathy, is a rare neurological complication that occurs in patients with chronic liver disease. There is no easy and feasible treatment, liver transplantation is the only accepted therapy that may be effective for patients at earl...
Autores principales: | Sun, Lin, Li, Jun, Lan, Li-Li, Li, Xiao-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641758/ https://www.ncbi.nlm.nih.gov/pubmed/31305466 http://dx.doi.org/10.1097/MD.0000000000016430 |
Ejemplares similares
-
Liver transplantation in hepatic myelopathy
por: Acar, Sencan, et al.
Publicado: (2022) -
Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study
por: Tian, Yan, et al.
Publicado: (2019) -
Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report
por: Huang, Hongli, et al.
Publicado: (2019) -
Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction
por: Wang, Wei-Wei, et al.
Publicado: (2017) -
Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
por: Kuai, Xiao-yi, et al.
Publicado: (2021)